[ Price : $8.95]
A new article in the New England Journal of Medicine warns that recent federal court rulings are transforming FDA-required drug la...[ Price : $8.95]
CBER faces mounting scrutiny after its top official, director Vinay Prasad, refused the review of Modernas flu vaccine application...[ Price : $8.95]
FDA releases the form FDA-483 with 11 observations from an inspection at Indias Eugia Pharma Specialties sterile drug manufacturin...[ Price : $8.95]
FDA awards Krystal Biotech a Regenerative Medicine Advanced Therapy designation for KB707, an inhalable gene therapy being investi...[ Price : $8.95]
FDA approves Mercks Keytruda (pembrolizumab), as well as the fixed-dose combination pembrolizumab and berahyaluronidase alfa-pmph ...[ Price : $8.95]
FDA cites AGC Biologics for deficiencies in laboratory data controls and inventory management at its Bothell, WA, drug substance m...[ Price : $8.95]
FDA accepts for review a Biofrontera supplemental NDA seeking to expand the label of its photodynamic therapy drug Ameluz (aminole...[ Price : $8.95]
FDA posts a draft guidance entitled Certification Process for Designated Medical Gases.